PharmSci 360 Scientific Programming Committee
Kevin Litwiler, Ph.D., Pfizer (Chair)
Otilia Koo, Ph.D., BMS (Vice Chair)
Mark Arnold, Ph.D., FAAPS, Labcorp (Past Chair)
Faye Vazvaei-Smith, M.S., Merck (AAPS Board of Directors Liaison)
Discovery and Basic Research Track
Tamer Fandy, Ph.D., University of Charleston (Track Chair)
Zhenzhen Dong, Ph.D., MSc, Adesis, Inc. (Sub-Track Leader, Biomolecular)
Rick Gemeinhart, Ph.D., University of Illinois Chicago (Sub-Track Leader, Chemical)
Preclinical Development Track
Jae Chang, Ph.D., ORIC Pharmaceuticals (Track Chair)
Naveen Thakral, Ph.D., Boehringer Ingelheim Pharmaceuticals, Inc. (Sub-Track Leader, Biomolecular)
Yasuhiro Tsume, Ph.D. Merck (Sub-Track Leader, Chemical)
Bioanalytics Track
Amanda Hays, Ph.D., BioAgilytix (Track Chair)
William Hallett, Ph.D., Janssen (Sub-Track Leader, Biomolecular)
Matthew Halquist, Ph.D., Virginia Commonwealth University (Sub-Track Leader, Chemical)
Clinical Pharmacology Track
Amit Desai, Ph.D., Astellas Pharma (Track Chair)
Galina Bernstein, Ph.D., Camargo Pharmaceutical Services (Sub-Track Leader, Biomolecular)
Vaishali Sahasrabudhe, Ph.D., Pfizer (Sub-Track Leader, Chemical)
Manufacturing and Analytical Characterization Track
Narayan Variankaval, Ph.D., Merck (Track Chair)
Sayantan Chattoraj, Ph.D., GlaxoSmithKline (Sub-Track Leader, Biomolecular)
Maria Cruanes, Ph.D., Organon (Sub-Track Leader, Chemical)
Formulation and Delivery Track
Nikoletta Fotaki, Ph.D., FAAPS, University of Bath (Track Chair)
Shuhua Bai, Ph.D., Husson University (Sub-Track Leader, Biomolecular)
Jaymin Shah, Ph.D., Pfizer (Sub-Track Leader, Chemical)